A preclinical model demonstrated that IL-15 deficiency increased tumor burden due to NK and CD8 + T cell immunodeficiency as well as the inflammatory environment supporting tumors, suggesting that intestinal homeostasis and inhibiting inflammation-induced tumorigenesis were dependent on IL-15 (127). The gene discussed is IL15; the disease is neoplasm.